Chief Scientific Officer
Research & Development
MiNA therapeutics
United Kingdom
David has over 25 years of drug discovery and development experience and is an industry leader in the development of oligonucleotide therapeutics. Prior to joining MiNA David held multiple roles at AstraZeneca, mostly recently Chief Scientist in Oncology. David holds a PhD from MRC Laboratories in Drug Metabolism and Toxicology and is a Director of the Oligonucleotide Therapeutics Society.
Oncology,Toxicology